Abstract Human papillomavirus (HPV)-positive (HPV+) oropharyngeal squamous cell
carcinoma (OPSCC) has one of the most rapidly increasing incidences of any cancer in high …

Purpose To understand why some patients respond to immunotherapy but many do not, a
clear picture of the tumor microenvironment (TME) of head and neck squamous cell …

TP53 mutation is one of the most frequent genetic alterations in head and neck squamous
cell carcinoma (HNSCC) and results in an accumulation of p53 protein in tumor cells. This …

Over the past few decades, with the rise of immunotherapies, tumor infiltrating immune cells
were increasingly investigated. Indeed, they may represent biomarkers for patient outcome …

Head and neck squamous cell carcinoma (HNSCC) is an immunogenic cancer type, and
tumor associated macrophages (TAMs) are a major component of the tumor …

Head and neck squamous cell carcinomas (HNSCC) are one of the most prevalent cancers
worldwide. Active human papillomavirus (HPV) infection has been identified as an important …

Background Undifferentiated pleomorphic sarcoma (UPS) is the most frequent, aggressive
and less-characterized sarcoma subtype. This study aims to assess UPS molecular …

Objectives: To review the current knowledge regarding the involvement of human papilloma
virus (HPV) infection and the immune system in the development of head and neck …

Objective The immune microenvironment of HPV‐associated (HPV+) oropharyngeal
squamous cell carcinomas (OPSCCs)(HPV+ OPSCCs) differs from that of HPV‐independent …

Background Human papillomavirus (HPV)-associated oropharyngeal squamous cell
carcinoma (OPSCC) is a distinct clinical entity with a much better prognosis after (chemo) …